Skip to content

TO STUDY EFFECT OF DURALABHADI LEHA IN TAMAKASHWAS(CHILDHOOD ASTHMA) IN CHILDREN

A single arm clinical study to evaluate the efficacy of duralabhadi leha in the management of tamakashwas in children. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066714
Enrollment
35
Registered
2024-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Sponsors

Dr Pranjali Undre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Children having symptoms of Tamaka Shwasa as mentioned by Charak : Shwasakruchhrata (Dyspnea) Kasa (Cough) Ghur-Ghurak Shabda (Wheezing) Kashten Shleshma Moksha (Difficulty in Expectorant) Peenas 2)Children of age Group 1 year to 12 years. 3) Children who has a family history of asthma with a symptoms of Tamaka Shwasa. 4)Chidren who are ready to participate in the clinical trial by giving informed written consent.

Exclusion criteria

Exclusion criteria: 1)Patients having life threatening illness and who are bed ridden. 2)Patients having any congenital respiratory and GIT abnormality. 3)Patients who require surgical management. 4)Patients with known case of Pulmonary Tuberculosis, Pleural effusion, Emphysema, Bronchial Carcinoma, Status asthmatics 5)Patients having other systemic major illness like Immunocompromise diseases, Cardiac Disease, Renal Failure. 6)Patient with severe Asthmatic condition who needs Emergency treatment.

Design outcomes

Primary

MeasureTime frame
To decrease breathing difficulty and cough in childrenTimepoint: 7 Days study with followup on 4th day and 7th day (0,4,7 Days)

Secondary

MeasureTime frame
To study the Adverse effect of Duralabhadi leha, if anyTimepoint: 7 Days study with followup on 4th day and 7th day (0,4,7 Days)

Countries

India

Contacts

Public ContactDr Pranjali Undre

DR. D.Y. PATIL COLLEGE OF AYURVED ,PIMPRI PUNE.

drdeepak77@rediffmail.com9923220055

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026